相关实验视频

Updated: May 27, 2025

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Published on: February 6, 2020

与CHEK2相关的乳腺癌:现实世界的挑战

Luiza N Weis¹, Brittany L Bychkovsky^2,3,4,5, Adela Rodríguez Hernandez^2,3,5,6,7

¹Dasa Oncology, Hospital Brasília, Brasília, Brazil.

Familial cancer

|February 18, 2025

概括

管理CHEK2基因携带者的癌症风险是复杂的. 本案例系列强调了对巴西CHEK2携带者的乳腺癌监测和风险降低方面的挑战,并强调了需要改进的评估策略的需要.

科学领域:

在瘤学瘤学.
遗传学遗传学是一个
癌症风险评估癌症风险评估

背景情况:

CHEK2是一种中度透基因,与乳腺癌风险有关.
对CHEK2载体的管理带来了现实世界的临床挑战.
家庭病史和遗传变异改变了CHEK2载体的乳腺癌风险.

研究的目的:

介绍一系列巴西乳腺癌患者携带CHEK2变异的病例.
突出临床珍珠和知识差距在管理CHEK2相关的癌症风险.

主要方法:

对12名患有乳腺癌和致病性/可能致病性CHEK2变异的妇女进行描述性分析.
巴西西里奥利巴内斯医院评估的患者 (2017年11月至2021年7月).
纳入标准:个人乳腺癌史和生殖线CHEK2变异.

主要成果:

所有12名女性都患有早期乳腺癌,大多数在50岁之前被诊断出 (9/12).
在12名患者中,有9名患者有乳腺癌家族史.
七名患者具有内源性致病性CHEK2变异;对非欧洲祖先携带者发现知识差距.

结论:

改善癌症风险评估和预防策略对于CHEK2携带者至关重要.
目前对CHEK2载体的临床管理面临重大挑战.
需要进一步的研究,以解决风险修饰因子和特定的CHEK2变异.

关键词:

CHEK2 是一个国家.乳腺癌乳腺癌乳腺癌适度的透度适度的透度风险管理风险管理

更多相关视频

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...